Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1083213.RApNkglV7nvTLihyvHgUbch7j_5wcXSEcIYtDg35e_Adc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1083213.RApNkglV7nvTLihyvHgUbch7j_5wcXSEcIYtDg35e_Adc130_assertion type Assertion NP1083213.RApNkglV7nvTLihyvHgUbch7j_5wcXSEcIYtDg35e_Adc130_head.
- NP1083213.RApNkglV7nvTLihyvHgUbch7j_5wcXSEcIYtDg35e_Adc130_assertion description "[Increased RGS17 expression in some prostate and lung cancers has been demonstrated to support cancer progression, while reduced expression of RGS17 can lead to development of chemotherapeutic resistance in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1083213.RApNkglV7nvTLihyvHgUbch7j_5wcXSEcIYtDg35e_Adc130_provenance.
- NP1083213.RApNkglV7nvTLihyvHgUbch7j_5wcXSEcIYtDg35e_Adc130_assertion evidence source_evidence_literature NP1083213.RApNkglV7nvTLihyvHgUbch7j_5wcXSEcIYtDg35e_Adc130_provenance.
- NP1083213.RApNkglV7nvTLihyvHgUbch7j_5wcXSEcIYtDg35e_Adc130_assertion SIO_000772 23734683 NP1083213.RApNkglV7nvTLihyvHgUbch7j_5wcXSEcIYtDg35e_Adc130_provenance.
- NP1083213.RApNkglV7nvTLihyvHgUbch7j_5wcXSEcIYtDg35e_Adc130_assertion wasDerivedFrom befree-2016 NP1083213.RApNkglV7nvTLihyvHgUbch7j_5wcXSEcIYtDg35e_Adc130_provenance.
- NP1083213.RApNkglV7nvTLihyvHgUbch7j_5wcXSEcIYtDg35e_Adc130_assertion wasGeneratedBy ECO_0000203 NP1083213.RApNkglV7nvTLihyvHgUbch7j_5wcXSEcIYtDg35e_Adc130_provenance.